1. Conlon, Thomas M, John-Schuster, Gerrit, Heide, Danijela, Heikenwalder, Mathias, Yildirim, Ali Önder. 2020. Inhibition of LTβR signalling activates WNT-induced regeneration in lung. In Nature, 588, 151-156. doi:10.1038/s41586-020-2882-8. https://pubmed.ncbi.nlm.nih.gov/33149305/
2. Xu, Kaiyu, Kessler, Annika, Nichetti, Federico, Goeppert, Benjamin, Köhler, Bruno C. 2024. Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma. In Liver international : official journal of the International Association for the Study of the Liver, 44, 2950-2963. doi:10.1111/liv.16069. https://pubmed.ncbi.nlm.nih.gov/39164890/
3. Wu, Yinteng, Zhao, Shijian, Guo, Wenliang, Rodrìguez, Raquel Alarcòn, Wei, Ruqiong. 2024. Systematic analysis of the prognostic value and immunological function of LTBR in human cancer. In Aging, 16, 129-152. doi:10.18632/aging.205356. https://pubmed.ncbi.nlm.nih.gov/38175686/
4. Kotov, Jessica A, Xu, Ying, Carey, Nicholas D, Cyster, Jason G. 2022. LTβR overexpression promotes plasma cell accumulation. In PloS one, 17, e0270907. doi:10.1371/journal.pone.0270907. https://pubmed.ncbi.nlm.nih.gov/35925983/
5. Wu, Guolin, Wu, Fangping, Zhou, Yang Qing, Hu, Feng Lin, Fan, Xiaofen. 2023. Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling. In PeerJ, 11, e15551. doi:10.7717/peerj.15551. https://pubmed.ncbi.nlm.nih.gov/37366426/
6. Grandoch, Maria, Feldmann, Kathrin, Göthert, Joachim R, Pfeffer, Klaus, Fischer, Jens W. 2015. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. In Circulation research, 116, e57-68. doi:10.1161/CIRCRESAHA.116.305723. https://pubmed.ncbi.nlm.nih.gov/25740843/
智鼠故事 
